A functional SNP of interferon-γ gene is important for interferon-α-induced and spontaneous recovery from hepatitis C virus infection

被引:94
|
作者
Huang, Ying
Yang, Huiying
Borg, Brian B.
Su, Xiaowen
Rhodes, Shannon L.
Yang, Kai
Tong, Xiaomei
Tang, George
Howell, Charles D.
Rosen, Hugo R.
Thio, Chloe L.
Thomas, David L.
Alter, Harvey J.
Sapp, Ronda K.
Liang, T. Jake [1 ]
机构
[1] NIH, Ctr Clin, Dept Transfus Med, Bethesda, MD 20892 USA
[2] NIDDKD, Liver Dis Branch, NIH, Bethesda, MD 20892 USA
[3] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA
[4] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[5] Univ Colorado, Hlth Sci Ctr, Div Gastroenterol Hepatol, Denver, CO 80262 USA
[6] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA
关键词
genetics; human study; cytokine; viral clearance; antiviral treatment;
D O I
10.1073/pnas.0609954104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cytokine polymorphisms are associated with disease outcome and interferon (IFN) treatment response in hepatitis C virus (HCV) infection. We genotyped eight SNPs spanning the entire IFN-gamma gene in two cohorts and assessed the association between those polymorphisms and treatment response or spontaneous viral clearance. The first cohort was composed of 284 chronically HCV-infected patients who had received IFN-alpha-based therapy and the second was 251 i.v. drug users who had either spontaneously cleared HCV or become chronically infected. A SNP variant located in the proximal IFN-gamma promoter region next to the binding motif of heat shock transcription factor (HSF), -764G, was significantly associated with sustained virological response [P = 0.04, odds ratio (OR) = 3.51 (confidence interval 1.0-12.5)]. The association was independently significant in multiple logistic regression (P = 0.04) along with race, viral titer, and genotype. This variant was also significantly associated with spontaneous recovery [P = 0.04, OR = 3.51 (1.0-12.5)] in the second cohort. Functional analyses show that the G allele confers a two- to three-fold higher promoter activity and stronger binding affinity to HSF1 than the C allele. Our study suggests that the IFN-gamma promoter SNP -764G/C is functionally important in determining viral clearance and treatment response in HCV-infected patients and may be used as a genetic marker to predict sustained virological response in HCV-infected patients.
引用
收藏
页码:985 / 990
页数:6
相关论文
共 50 条
  • [21] Interferon-α-Induced TRAIL on Natural Killer Cells Is Associated With Control of Hepatitis C Virus Infection
    Stegmann, Kerstin A.
    Bjorkstrom, Niklas K.
    Veber, Heike
    Ciesek, Sandra
    Riese, Peggy
    Wiegand, Johannes
    Hadem, Johannes
    Suneetha, Pothakamuri V.
    Jaroszewicz, Jerzy
    Wang, Chun
    Schlaphoff, Verena
    Fytili, Paraskevi
    Cornberg, Markus
    Manns, Michael P.
    Geffers, Robert
    Pietschmann, Thomas
    Guzman, Carlos A.
    Ljunggren, Hans-Gustaf
    Wedemeyer, Heiner
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : 1885 - U68
  • [22] Genetic Polymorphism of Interferon-γ, Interferon-γ Receptor, and Interferon Regulatory Factor-1 Genes in Patients with Hepatitis B Virus Infection
    Jae Youn Cheong
    Sung Won Cho
    Soon Gee Chung
    Jung A. Lee
    Marie Yeo
    Hee Jung Wang
    Jong Eun Lee
    Ki Baik Hahm
    Jin Hong Kim
    [J]. Biochemical Genetics, 2006, 44 : 246 - 255
  • [23] Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-α
    Zylberberg, H
    Chaix, ML
    Bréchot, C
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (10) : 845 - 846
  • [24] Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-α
    Akriviadis, EA
    Xanthakis, I
    Navrozidou, C
    Papadopoulos, A
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1997, 25 (04) : 612 - 618
  • [25] Interferon-α alone versus interferon-α plus ribavirin in patients with chronic hepatitis C not responding to previous interferon-α treatment
    Tripi, S
    Di Gaetano, G
    Soresi, M
    Cartabellotta, F
    Vassallo, R
    Carroccio, A
    Anastasi, G
    Montalto, G
    [J]. BIODRUGS, 2000, 13 (04) : 299 - 304
  • [26] Differences between interferon-α and -β treatment for patients with chronic hepatitis C virus infection
    Furusyo, N
    Hayashi, J
    Ohmiya, M
    Sawayama, Y
    Kawakami, Y
    Ariyama, I
    Kinukawa, N
    Kashiwagi, S
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (03) : 608 - 617
  • [27] Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-α
    Sherman, M
    Marinos, G
    Sedarati, F
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 135 (10) : 927 - 928
  • [28] Longterm efficacy of interferon-α for extrahepatic disease associated with hepatitis C virus infection
    Naarendorp, M
    Kallemuchikkal, U
    Nuovo, GJ
    Gorevic, PD
    [J]. JOURNAL OF RHEUMATOLOGY, 2001, 28 (11) : 2466 - 2473
  • [29] Treatment with ribavirin and interferon-α reduces interferon-γ expression in patients with chronic hepatitis C
    Bergamini, A
    Bolacchi, F
    Cepparulo, M
    Demin, F
    Uccella, I
    Bongiovanni, B
    Ombres, D
    Angelico, F
    Liuti, A
    Hurtova, M
    Francioso, S
    Carvelli, C
    Cerasari, G
    Angelico, M
    Rocchi, G
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (03): : 459 - 464
  • [30] The NS5a gene of hepatitis C virus in patients treated with interferon-α
    McKechnie, VM
    Mills, PR
    McCruden, EAB
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2000, 60 (04) : 367 - 378